NDUFS5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.142800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.950800E-01
Normal-vs-Stage2
4.992400E-01
Normal-vs-Stage3
6.226400E-01
Normal-vs-Stage4
8.949000E-01
Stage1-vs-Stage2
4.970800E-01
Stage1-vs-Stage3
6.122400E-01
Stage1-vs-Stage4
9.607400E-01
Stage2-vs-Stage3
7.376000E-01
Stage2-vs-Stage4
5.299400E-01
Stage3-vs-Stage4
5.947400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.400800E-01
Normal-vs-AfricanAmerican
6.207800E-01
Normal-vs-Asian
3.142400E-01
Caucasian-vs-AfricanAmerican
8.026200E-01
Caucasian-vs-Asian
2.882800E-01
AfricanAmerican-vs-Asian
3.326600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.616000E-01
Normal-vs-Female
4.662400E-01
Male-vs-Female
7.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.977000E-01
Normal-vs-Age(41-60Yrs)
3.690200E-01
Normal-vs-Age(61-80Yrs)
5.633600E-01
Normal-vs-Age(81-100Yrs)
4.863600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.446000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.657600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.243400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.472200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.221800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.269200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.991000E-01
Normal-vs-Daily Drinker
3.924000E-01
Normal-vs-Weekly Drinker
4.470400E-01
Normal-vs-Occasional Drinker
3.376600E-01
Normal-vs-Social Drinker
2.875600E-01
Non Drinker-vs-Daily Drinker
1.722760E-01
Non Drinker-vs-Weekly Drinker
3.377600E-01
Non Drinker-vs-Occasional Drinker
3.080800E-01
Non Drinker-vs-Social Drinker
2.014400E-01
Daily Drinker-vs-Weekly Drinker
7.943200E-01
Daily Drinker-vs-Occasional Drinker
6.637600E-01
Daily Drinker-vs-Social Drinker
9.536200E-01
Weekly Drinker-vs-Occasional Drinker
9.036800E-01
Weekly Drinker-vs-Social Drinker
8.192200E-01
Occasional Drinker-vs-Social Drinker
6.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.918200E-01
Normal-vs-Grade 2
8.993400E-01
Normal-vs-Grade 3
9.464200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.105400E-01
Grade 1-vs-Grade 3
9.875000E-01
Grade 1-vs-Grade 4
8.918200E-01
Grade 2-vs-Grade 3
3.848400E-01
Grade 2-vs-Grade 4
8.993400E-01
Grade 3-vs-Grade 4
9.464200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.598800E-01
Normal-vs-NonDiabetic
3.785400E-01
Diabetic-vs-NonDiabetic
1.115960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.392000E-01
Normal-vs-NoPancreatitis
5.210000E-01
Pancreatitis-vs-NoPancreatitis
4.971200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.034200E-01
Normal-vs-N1
5.206800E-01
N0-vs-N1
9.831000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.323600E-01
Normal-vs-TP53-NonMutant
9.848400E-01
TP53-Mutant-vs-TP53-NonMutant
5.075000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
